Samah Nassereddine: Shaping a Better Future in AML Treatment
Samah Nassereddine/LinkedIn

Samah Nassereddine: Shaping a Better Future in AML Treatment

Samah Nassereddine, Associate Program Director at Luminis Health and Associate Professor of Medicine at The George Washington University School of Medicine and Health Sciences, shared a post on LinkedIn:

‘We owe it to our patients to do better’

This is how I ended up my session on acute myeloid leukemia at the Hematology updates held last Saturday. This conference is a great opportunity to connect with colleagues and brainstorm on how to shape a better tomorrow for our patients.

Advocating for our patients should know no limit. The years of stagnation in AML treatment are behind us…cure is near.
Samah Nassereddine: Shaping a Better Future in AML Treatment

Other articles about AML on OncoDaily.